fromilid 250 mg filmsko obložene tablete
krka, d.d., novo mesto - klaritromicin - filmsko obložena tableta - klaritromicin 250 mg / 1 tableta - klaritromicin
fromilid za otroke 50 mg/ml zrnca za peroralno suspenzijo
krka, d.d., novo mesto - klaritromicin - zrnca za peroralno suspenzijo - klaritromicin 50 mg / 1 ml - klaritromicin
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotična sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
simvastatin lek 40 mg filmsko obložene tablete
lek d.d. - simvastatin - filmsko obložena tableta - simvastatin 40 mg / 1 tableta - simvastatin
simvastatin lek 20 mg filmsko obložene tablete
lek d.d. - simvastatin - filmsko obložena tableta - simvastatin 20 mg / 1 tableta - simvastatin
simvastatin lek 40 mg filmsko obložene tablete
lek d.d. - simvastatin - filmsko obložena tableta - simvastatin 40 mg / 1 tableta - simvastatin
simvastatin lek 20 mg filmsko obložene tablete
lek d.d. - simvastatin - filmsko obložena tableta - simvastatin 20 mg / 1 tableta - simvastatin
inegy 10 mg/40 mg tablete
merck sharp & dohme, d.o.o. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta simvastatin40 mg / 1 tableta; simvastatin 40 mg / 1 tableta - simvastatin in ezetimib
inegy 10 mg/20 mg tablete
merck sharp & dohme, d.o.o. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta simvastatin20 mg / 1 tableta; simvastatin 20 mg / 1 tableta - simvastatin in ezetimib
inegy 10 mg/10 mg tablete
merck sharp & dohme, d.o.o. - ezetimib; simvastatin - tableta - ezetimib 10 mg / 1 tableta simvastatin10 mg / 1 tableta; simvastatin 10 mg / 1 tableta - simvastatin in ezetimib